CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $500,000 | +112.8% | 9,672 | +2.1% | 0.01% | +150.0% |
Q2 2022 | $235,000 | +40.7% | 9,470 | +42.0% | 0.00% | +100.0% |
Q1 2022 | $167,000 | -68.1% | 6,669 | -53.7% | 0.00% | -50.0% |
Q4 2021 | $524,000 | +44.8% | 14,396 | +103.9% | 0.00% | -85.7% |
Q1 2021 | $362,000 | -24.6% | 7,060 | -8.9% | 0.01% | -22.2% |
Q4 2020 | $480,000 | +13.7% | 7,750 | +0.5% | 0.02% | 0.0% |
Q3 2020 | $422,000 | +3.2% | 7,709 | +8.4% | 0.02% | -5.3% |
Q2 2020 | $409,000 | +41.5% | 7,114 | -1.1% | 0.02% | +171.4% |
Q1 2020 | $289,000 | -0.3% | 7,192 | -2.0% | 0.01% | +40.0% |
Q4 2019 | $290,000 | – | 7,339 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |